ArticleInfectious diseases and therapy2022

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.

Iris De Ryck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.